IKT

US

Inhibikase Therapeutics Inc

--
--(--)

Price

Key Statistics

Open

--

High

--

Low

--

Prev Close

--

Volume

--

Avg Volume

--

Market Cap

--

P/E Ratio

--

Forward P/E

--

EPS

--

Beta

--

52W High

--

52W Low

--

Dividend

--

Div Yield

--

Who's bullish on IKT

Across the groups Alpha Bazaar tracks. Not investment advice.

See who's been right ›

Analyst Ratings (Last 90 Days)

Consensus

neutral

Based on 1 analyst ratings

Price Target

$1.50avg (1 analysts)
High: $1.50Low: $1.50

Recent Ratings

Chardan Capitalneutral
Andreas Argyrides · 10/13/2026 · PT: $1.50

Recent News